Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

MALT1 gene rearrangements and NF-kappaB activation involving p65 and p50 are absent or rare in primary MALT lymphomas of the breast.

Talwalkar SS, Valbuena JR, Abruzzo LV, Admirand JH, Konoplev SN, Bueso-Ramos CE, Medeiros LJ.

Mod Pathol. 2006 Nov;19(11):1402-8. Epub 2006 Aug 18.

2.

MALT lymphoma involving the kidney: a report of 10 cases and review of the literature.

Garcia M, Konoplev S, Morosan C, Abruzzo LV, Bueso-Ramos CE, Medeiros LJ.

Am J Clin Pathol. 2007 Sep;128(3):464-73. Review.

PMID:
17709321
3.
4.

Nuclear factor kappaB activation and antiapoptosis in mucosa-associated lymphoid tissue lymphoma.

Hosokawa Y, Seto M.

Int J Hematol. 2004 Oct;80(3):215-23. Review.

PMID:
15540895
5.

Molecular pathogenesis of mucosal-associated lymphoid tissue (MALT) lymphoma.

Gascoyne RD.

Leuk Lymphoma. 2003;44 Suppl 3:S13-20. Review.

PMID:
15202520
6.

MALT lymphoma: many roads lead to nuclear factor-κb activation.

Du MQ.

Histopathology. 2011 Jan;58(1):26-38. doi: 10.1111/j.1365-2559.2010.03699.x. Review.

PMID:
21261681
7.

Etiology and therapy of Helicobacter pylori-associated gastric lymphomas.

Wündisch T, Kim TD, Thiede C, Morgner A, Alpen B, Stolte M, Neubauer A.

Ann Hematol. 2003 Sep;82(9):535-45. Epub 2003 Jul 3. Review.

PMID:
12845479
8.

Update on MALT lymphomas.

Isaacson PG.

Best Pract Res Clin Haematol. 2005 Mar;18(1):57-68. Review.

PMID:
15694184
9.

Molecular pathogenesis of mucosa-associated lymphoid tissue lymphoma.

Farinha P, Gascoyne RD.

J Clin Oncol. 2005 Sep 10;23(26):6370-8. Review.

PMID:
16155022
10.
11.

Pathobiology of primary mediastinal B-cell lymphoma.

Pileri SA, Zinzani PL, Gaidano G, Falini B, Gaulard P, Zucca E, Sabattini E, Ascani S, Rossi M, Cavalli F; International Extranodal Lymphoma Study Group..

Leuk Lymphoma. 2003;44 Suppl 3:S21-6. Review.

PMID:
15202521
12.

Primary thyroid lymphomas.

Widder S, Pasieka JL.

Curr Treat Options Oncol. 2004 Aug;5(4):307-13. Review.

PMID:
15233907
13.

Molecular pathogenesis and histologic and clinical features of extranodal marginal zone lymphomas of mucosa-associated lymphoid tissue type.

Kuper-Hommel MJ, van Krieken JH.

Leuk Lymphoma. 2012 Jun;53(6):1032-45. doi: 10.3109/10428194.2011.631157. Epub 2012 Jan 3. Review.

PMID:
21988643
14.
15.
16.

Bilateral breast MALT lymphoma: a case report and review of the literature.

Gopal S, Awasthi S, Elghetany MT.

Ann Hematol. 2000 Feb;79(2):86-9. Review.

PMID:
10741921
17.

Protease activity of the API2-MALT1 fusion oncoprotein in MALT lymphoma development and treatment.

Rosebeck S, Lucas PC, McAllister-Lucas LM.

Future Oncol. 2011 May;7(5):613-7. doi: 10.2217/fon.11.35. Review.

18.

The pathogenesis of MALT lymphomas: where do we stand?

Sagaert X, De Wolf-Peeters C, Noels H, Baens M.

Leukemia. 2007 Mar;21(3):389-96. Epub 2007 Jan 18. Review.

PMID:
17230229
19.

MALT1 protease: a new therapeutic target in B lymphoma and beyond?

McAllister-Lucas LM, Baens M, Lucas PC.

Clin Cancer Res. 2011 Nov 1;17(21):6623-31. doi: 10.1158/1078-0432.CCR-11-0467. Epub 2011 Aug 25. Review.

20.

Gastric lymphomas: genetics and resistance to H. pylori eradication.

Isaacson PG, Du MQ.

Verh Dtsch Ges Pathol. 2003;87:116-22. Review.

PMID:
16888902

Supplemental Content

Support Center